摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[1-(7-chloro-4-quinolyl)-4-piperidyl]-1-[(4-fluorophenyl)methyl]benzimidazol-2-amine | 1123619-93-1

中文名称
——
中文别名
——
英文名称
N-[1-(7-chloro-4-quinolyl)-4-piperidyl]-1-[(4-fluorophenyl)methyl]benzimidazol-2-amine
英文别名
N-[1-(7-chloroquinolin-4-yl)piperidin-4-yl]-1-[(4-fluorophenyl)methyl]benzimidazol-2-amine
N-[1-(7-chloro-4-quinolyl)-4-piperidyl]-1-[(4-fluorophenyl)methyl]benzimidazol-2-amine化学式
CAS
1123619-93-1
化学式
C28H25ClFN5
mdl
——
分子量
485.991
InChiKey
PLLAJNLKAWWLGN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    698.9±65.0 °C(predicted)
  • 密度:
    1.35±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    6.7
  • 重原子数:
    35
  • 可旋转键数:
    5
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.21
  • 拓扑面积:
    46
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    参考文献:
    名称:
    Chloroquine–astemizole hybrids with potent in vitro and in vivo antiplasmodial activity
    摘要:
    A dual activity, conjugated approach has been taken to form hybrid molecules of two known antimalarial drugs, chloroquine (CQ) and the non-sedating H1 antagonist astemizole. A variety of linkers were investigated to conjugate the two agents into one molecule. Compounds 5-8 possessed improved in vitro activity against a CQ-resistant strain of Plasmodium falciparum, and examples 7 and 8 were active in vivo in mouse models of malaria. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2008.11.047
点击查看最新优质反应信息

文献信息

  • Chloroquine–astemizole hybrids with potent in vitro and in vivo antiplasmodial activity
    作者:Chitalu C. Musonda、Gavin A. Whitlock、Michael J. Witty、Reto Brun、Marcel Kaiser
    DOI:10.1016/j.bmcl.2008.11.047
    日期:2009.1
    A dual activity, conjugated approach has been taken to form hybrid molecules of two known antimalarial drugs, chloroquine (CQ) and the non-sedating H1 antagonist astemizole. A variety of linkers were investigated to conjugate the two agents into one molecule. Compounds 5-8 possessed improved in vitro activity against a CQ-resistant strain of Plasmodium falciparum, and examples 7 and 8 were active in vivo in mouse models of malaria. (C) 2008 Elsevier Ltd. All rights reserved.
查看更多